| |
| |
|
| Insider
Information: |
Casamento Charles J |
| Relationship: |
Director |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
268,219 |
|
|
Indirect Shares
|
138,482 |
|
|
| Direct
Value |
$12,902 |
|
|
|
Indirect Value
|
$91,271 |
|
|
| Total
Shares |
406,701 |
|
|
| Total
Value |
$104,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
RespireRx Pharmaceuticals Inc |
RSPI |
Director |
2007-11-30 |
15,000 |
2005-02-08 |
0 |
Premium* |
|
|
Astex Pharmaceuticals Inc |
ASTX |
Director |
2013-05-03 |
0 |
2005-08-05 |
0 |
Premium* |
|
|
Osteologix, Inc. |
OLGXF |
Officer, Director |
2006-05-24 |
57,420 |
|
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-01-25 |
87,125 |
2011-12-06 |
0 |
Premium* |
|
|
International Stem Cell Corp |
ISCO |
Director |
2018-06-21 |
14,431 |
2012-05-29 |
0 |
Premium* |
|
|
Relmada Therapeutics, Inc. |
RLMD |
Director |
2022-04-01 |
0 |
2020-09-01 |
21,484 |
Premium* |
|
|
First Wave Biopharma Ord Shs |
FWBI |
Director |
2024-01-02 |
19,937 |
2020-03-19 |
116,998 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
Director |
2019-08-09 |
71,920 |
2018-11-15 |
0 |
Premium* |
|
|
Paxmedica, Inc. |
PXMD |
Director |
2024-03-12 |
2,386 |
2022-10-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2017-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
17,500 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2018-03-29 |
4 |
A |
$3.14 |
$23,550 |
D/D |
7,500 |
32,500 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
40,000 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2018-09-28 |
4 |
A |
$2.57 |
$19,275 |
D/D |
7,500 |
47,500 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2018-12-28 |
4 |
A |
$1.29 |
$9,675 |
D/D |
7,500 |
64,000 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2018-12-28 |
4 |
B |
$1.41 |
$12,690 |
D/D |
9,000 |
56,500 |
0.01 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2019-03-31 |
4 |
A |
$2.42 |
$18,150 |
D/D |
7,500 |
71,500 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2019-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
101,500 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2019-06-30 |
4 |
A |
$1.70 |
$12,750 |
D/D |
7,500 |
79,000 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2019-09-30 |
4 |
A |
$0.60 |
$4,500 |
D/D |
7,500 |
86,500 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2019-12-31 |
4 |
A |
$1.04 |
$7,800 |
D/D |
7,500 |
94,000 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2020-03-11 |
4 |
A |
$0.60 |
$17,501 |
D/D |
22,998 |
116,998 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2020-03-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
107,998 |
0 |
- |
|
| FWBI |
First Wave Biopharma Ord ... |
|
– • – |
2020-03-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
9,000 |
116,998 |
0 |
- |
|
| OLGXF |
Osteologix, Inc. |
CEO and PresidentOfficer |
• • – |
2006-05-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
57,420 |
|
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
Director |
– • – |
2005-02-08 |
4 |
B |
$2.67 |
$6,675 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
Director |
– • – |
2005-02-09 |
4 |
OE |
$0.38 |
$5,682 |
D/D |
15,153 |
17,653 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Director |
– • – |
2005-08-05 |
4 |
OE |
$2.76 |
$69,000 |
D/D |
25,000 |
25,000 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Director |
– • – |
2005-08-09 |
5 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
0 |
0 |
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
Director |
– • – |
2007-11-30 |
4 |
B |
$0.50 |
$7,500 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2011-12-06 |
4 |
OE |
$4.23 |
$105,750 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2011-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
62,125 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2012-03-12 |
4 |
OE |
$7.67 |
$328,460 |
D/D |
37,000 |
65,000 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2012-03-12 |
4 |
S |
$20.14 |
$745,217 |
D/D |
(37,000) |
61,000 |
0 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2012-04-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
36,000 |
26,125 |
0 |
- |
|
101 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
